Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 2Genitourinary 1

Conditions

Prostatic Neoplasms 3Anemia 2Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Fatigue 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Critical Illness 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Therapeutics 5Methylphenidate 3Exercise 3Sunitinib 2Psychiatric Rehabilitation 2Physical Therapy Modalities 2isoquercitrin 1enzalutamide 1darolutamide 1apalutamide 1Transcranial Magnetic Stimulation 1Surveys and Questionnaires 1Sugars 1Qigong 1Nutritional Support 1Neurofeedback 1Methods 1Lactose 1High-Intensity Interval Training 1Epoetin Alfa 1Early Intervention, Educational 1Dexamethasone 1Darbepoetin alfa 1Creatine 1Counseling 1Cognitive Behavioral Therapy 1Acupuncture Therapy 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fatigue × Darbepoetin alfa × Genitourinary × Clear all
NCT00381836 2015-12-04

Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer

University of Aarhus

Phase 2/3 Terminated
140 enrolled
Classical hematologyGenitourinary

Anemia, Fatigue, Neoplasms, Prostatic Neoplasms, Critical Illness

Data powered by HemOnc (CC BY 4.0) Colophon âš¡